Skip to main content

Table 1 Clinical features of MM patients

From: Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma

No. patients

12

Gender

7M-5F

Age median (Range)

61(35-76)

Type of M-protein

IgG(5), IgA(3), IgD(1).

 

Light chain(2), non-secretory(1)

Stage at diagnosis (Durie-Salmon)

Stage IIA: 3(25%)

 

Stage IIIA:7 (58.3%)IIIB: 2(16.7%)

Bone disease status at diagnosis

no osteolytic lesions:2(16.7%)

 

one to three lytic bone lesions:4(33.3%)

 

more than three lytic lesions:6(50%)